Nick Sleep is a Principal Associate with Cambridge Healthcare & Biotech.
Nick is an experienced general manager within early-stage lifescience businesses. His primary focus is on helping new ventures develop their commercial value propositions and supporting them whilst they build their teams. Examples include helping companies position themselves to raise finance, facilitating interactions with regulatory organisations relating to embryonic stem-cell derived cell therapies and scoping development projects and quality and design frameworks for a medical device company.
Previously, as VP Business Development at the start-up proteomics company Procognia, Nick out-licensed the company’s platform technologies to companies such as Teva, Qiagen and SigmaAldrich. In this role, he was also a member of the executive team that floated a subsidiary on the Israeli Stock Exchange with a post-money valuation of $29m.
Whilst at The Automation Partnership, Nick ran the Informatics Business Unit which implemented major Business Process Re-engineering projects within early-stage discovery. There he created enterprise software systems that enabled scientists to order from corporate compound collections direct from their desktops.
Nick’s original background was in Computer Science with Masters degree from UMIST. He has developed several systems under GxP, and run complex multi man-year development projects. He also holds an MBA from Cranfield University.